Life Sciences Summit Speakers

Lisa DYson, PhD

CEO @ Air Protein


Neil Dhawan

CEO & Co-Founder @ Totus Medicines


Steve Meller

Ceo @ CH4 Global


Philip Johnson

SVP and Treasurer- Finance/Proc/GBS/ Strategy @ Lilly

Jason Pontin

Partner @ DCVC

David Berry

GP @ Flagship Pioneering


Kiersten Stead

Managing Partner @ DCVC Bio


Brad Robling

VP @ Lilly New Ventures


Life Sciences Summit Agenda

1pm ET – Dec 9, 2021

December 9, 2021

1:00pm – 1:10pm ET


1:10pm – 1:35pm ET

Dr. Kiersten Stead of DCVC Bio

This session will map the Life Sciences Technology and Investing landscape. Learn what is cutting edge and hear, first-hand, how a Managing Partner examines investing.

1:35pm – 1:55pm ET

David Berry, GP of Flagship Pioneering

This special session features David Berry, General Partner at Flagship Pioneering, who will share his expertise and insights from creating groundbreaking companies. David has co-founded more than 20 companies across Life Sciences and Sustainability, including Valo, where he serves as CEO. Other companies include Joule, Seres Therapeutics (NASDAQ: MCRB), T2Biosystems (NASDAQ: TTOO), Indigo AgricultureEvelo Biosciences

1:55pm – 2:30pm ET

Jason Pontin of DCVC

In this session, discover how Venture Firms analyze Life Sciences Startup Companies in various stages of development (Pre-seed, Seed, Series A, Series B), and how Founders should approach company-building, with this in mind.

2:30pm – 3:00pm ET

Dr. Lisa Dyson of Air Protein 

What is the state of Startups in the Life Science industry? In this fireside chat, Malcolm Robinson, Founder and Executive Director of BVCC, and Dr. Lisa Dyson, Founder and CEO of Air Protein, will discuss how to identify trends, opportunities, and challenges when building a Life Sciences company.

3:00pm – 3:10pm ET


10 Min 

3:10pm – 3:40pm ET

Philip Johnson & Brad Robling of Lilly – Strategic Perspective

As a Global leader in medicine, the Eli Lilly team has unique insights into life science entrepreneurship. In this session, you’ll learn about Eli Lilly’s strategic engagement with entrepreneurs, startups at all phases of their journey, and as an investor in companies and venture capital funds.

3:40pm – 4:20pm ET

CH4 Global Inc – Steve Meller, CEO

CH4 Global is using sustainable aquaculture to impact climate change at scale. CEO Steve Meller will take you on his journey as a Founder, discussing how CH4 Global developed a leading Life Sciences company. Steve has offered the following Problem Set for your evaluation and discussion – ‘See the CH4 Global Problem Set

4:20pm – 5:00pm ET

Totus Medicines – Neil Dhawan, CEO

Totus Medicines is making every disease treatable by making the total human genome druggable. Be the first to hear about their breakthrough drug discovery technology, and CEO and Founder Neil Dhawan’s experience bringing Totus to market. Neil has also provided two Problem Sets for your consideration – ‘See Totus Medicines’ ’Problem Sets 

5:00pm ET

Happy Hour / Networking

Network with the group, get questions answered, or simply socialize via Gather.Town.